CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1

Back

EHRA Premium Access

CaMKII as a therapeutic target in catecholaminergic polymorphic ventricular tachycardia type 1

Session: Neurohormonal disturbances and arrhythmias

Topic: Arrhythmias

Speaker: Mr M. Sadredini (Oslo, NO)

Event: EHRA 2021

Congress Presentation

Add to my library

About the speaker

Mr Mani Sadredini

University of Oslo, Oslo (Norway)

1 presentation

0 follower

5 more presentations in this session

The cardiac sympathetic network and cardiac electrical function

Speaker: Doctor T. Zaglia (Padova, IT)

Access

Slides

Video

Cardiomyocyte calcium signalling in cardiorenal syndrome

Speaker: Doctor G. Ruiz Hurtado (Madrid, ES)

Access

Slides

Video

Glucagon-like peptide-1 directly increases heart rate and shortens atrial refractoriness: an in vivo and ex vivo study in pigs

Speaker: Doctor A. Lubberding (Copenhagen, DK)

Access

Slides

Video

Characterisation and modelling of the abnormal electrophysiological response under beta-adrenergic stimulation in hypertrophic cardiomyopathy

Speaker: Mr R. Doste (Oxford, GB)

Access

Slides

Video

Neurohormonal disturbances and arrhythmias - discussion

Access

Video

Access the full session

Neurohormonal disturbances and arrhythmias

Speakers: Mr M. Sadredini, Doctor T. Zaglia, Doctor G. Ruiz Hurtado, Doctor A. Lubberding, Mr R. Doste

Access

About the event

EHRA 2021

23 April - 25 April 2021

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources